Anfield Capital Management, LLC Ark Genomic Revolution ETF (De Transaction History
Anfield Capital Management, LLC
- $207 Million
- Q1 2024
A detailed history of Anfield Capital Management, LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Anfield Capital Management, LLC holds 300 shares of ARKG stock, worth $6,867. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300Holding current value
$6,867% of portfolio
0.0%Shares
9 transactions
Others Institutions Holding ARKG
# of Institutions
317Shares Held
19.1MCall Options Held
1.49MPut Options Held
2.83M-
Main Management ETF Advisors, LLC San Francisco, CA2.69MShares$61.6 Million4.12% of portfolio
-
Morgan Stanley New York, NY1.96MShares$44.8 Million0.0% of portfolio
-
Wells Fargo & Company San Francisco, CA1.3MShares$29.8 Million0.01% of portfolio
-
Ubs Group Ag1.27MShares$29.1 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY1.13MShares$25.9 Million0.0% of portfolio